Account
Newsletter
17.05.2023
PMA Insights: Week 20 SPECIAL EDITION – ISPO...

We summarise ISPOR Annual 2023 including plenary sessions on artificial intelligence, real-world evi...

Read more
Publications
10.05.2023
ISPOR US 2023: Plenary Session 2 – AI wants ...

Our experts provide a detailed summary of Plenary Session 2 at ISPOR Annual 2023 on artificial intel...

Read more
Articles
24.08.2022
Healthcare apps and devices in the UK: Who picks u...

Digital therapeutics: a growing market The year is 2008 and Apple have just added a new category to ...

Read more
Articles
17.08.2022
AI could transform diabetes management to improve ...

Introduction Around the world, it is estimated that 422 million people have diabetes, that’s almos...

Read more
Articles
11.08.2022
What does it take to secure access to digital heal...

Introduction Digital health applications (apps) are designed to improve personalised care and popula...

Read more
Insider Insights
27.06.2022
Health innovation plan

France’s Health Innovation Plan 2030, announced by President Emmanuel Macron back in June 2021, wi...

Read more
Newsletter
15.09.2021
PMA Insight: Week 37 2021

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
Articles
02.06.2020
Artificial intelligence in market access

AI technologies are becoming increasingly relevant in many fields, such as business and marketing an...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.

Talk to an expert

Remap Consulting have significant experience working with pharmaceutical and biotech companies in helping them navigate global market access.​

Get in touch